The myocardial flow reserve in patients with heart failure with preserved ejection fraction

Heart Vessels. 2023 Mar;38(3):348-360. doi: 10.1007/s00380-022-02161-5. Epub 2022 Sep 1.

Abstract

To evaluate the myocardial flow reserve (MFR) and myocardial blood flow (MBF) parameters in patients with heart failure with preserved ejection fraction (HFpEF) and to assess their relationship with the severity of HF and the levels of soluble ST2 (sST2). A total of 59 consecutive patients (median age of 65.0 (58.0; 69.0) years) with non-obstructive coronary artery disease (CAD) and preserved EF were enrolled. Serum levels biomarkers were measured by enzyme immunoassay. MBF and MFR parameters were evaluated by dynamic CZT-SPECT. All patients were divided into two groups: group 1 comprised patients (n = 41) with HFpEF, and group 2 comprised those (n = 18) without HFpEF. In group 1 global MFR (gMFR) values were lower by 27.8% (p = 0.003) than in group 2. The values of gMFR correlated with NT-proBNP (r = - 0.290) and sST2 (r = -0.331) levels. Based on ROC-analysis, gMFR ≤ 2.27 (AUC = 0.746; p < 0.001) were associated with the presence of HFpEF. In patients with HFpEF (n = 41) the values of gMFR were related to NYHA classes (p < 0.001) and the parameters of diastolic dysfunction (p < 0.001). The values of gMFR ≤ 2.27 may be used for the evaluation of microvascular changes in patients with HFpEF and non-obstructive CAD.

Keywords: Diastolic dysfunction; Heart failure; Microvascular dysfunction; Myocardial blood flow; Myocardial flow reserve; Preserved ejection fraction.

MeSH terms

  • Biomarkers
  • Coronary Artery Disease* / diagnosis
  • Heart Failure*
  • Humans
  • Myocardium
  • Stroke Volume / physiology

Substances

  • Biomarkers